OrbiMed Advisors LLC's Form 4 filing
Repare Therapeutics Inc. (RPTX) · filed Aug 19, 2021
- Accession no.
- 0000947871-21-000950
- Filed
- Aug 19, 2021, 8:55 PM ET
- Trade date
- Aug 17-18, 2021
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 4 non-derivative transactions. Open-market sales total $693.2K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| OrbiMed Advisors LLCCIK 0001055951 | Director |
| OrbiMed Capital LLCCIK 0001157524 | Director |
| OrbiMed Capital GP VII LLCCIK 0001760648 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 17, 2021 | Common Stock | SSaleDisposed | −16,886 | $34.12 | −$576,150.32 | 3,259,439 | Indirect | Duplicate filing |
| Aug 17, 2021 | Common Stock | SSaleDisposed | −512 | $34.12 | −$17,469.44 | 98,688 | Indirect | Duplicate filing |
| Aug 18, 2021 | Common Stock | SSaleDisposed | −2,852 | $33.99 | −$96,939.48 | 3,256,857 | Indirect | Duplicate filing |
| Aug 18, 2021 | Common Stock | SSaleDisposed | −78 | $33.99 | −$2,651.22 | 98,610 | Indirect | Duplicate filing |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.